跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 1,167 条关于
“NT1”
全部
1,167
临床试验
766
药物
310
机构
7
资讯
84
2年前
Takeda Presents New Data on TAK-861 Orexin Agonist for Narcolepsy at Sleep Europe 2024
2年前
Takeda's TAK-861 Shows Promising Results in Phase 2b Trial for Narcolepsy Type 1
去年
Takeda's Oveporexton Shows Promising Results in Phase 2b Trial for Narcolepsy Type 1
上个月
Orexin Receptor Agonists Herald a New Era for Narcolepsy Type 1 Treatment
去年
Takeda's TAK-861 Shows Promise in Phase IIb Trial for Narcolepsy Type 1
去年
Centessa Pharmaceuticals Initiates Phase 2 Trial of ORX750 for Sleep-Wake Disorders
10天前
NEJM Publishes Phase 3 Data for Takeda's Oveporexton, the First Approved Orexin Agonist for Narcolepsy Type 1
去年
Alkermes Presents Positive Phase 1b Data for ALKS 2680 in Narcolepsy Type 2 and Idiopathic Hypersomnia
9个月前
Experimental Narcolepsy Drug Oveporexton Shows Cognitive Benefits in Phase 2 Trial
去年
Centessa Pharmaceuticals Appoints Stephen Kanes as Chief Medical Officer to Advance Orexin Agonist Program
第 1 页,共 9 页
上一页
下一页